[{"fusionName":"BCR--ABL1","junctionReadCount":"2261","spanningFragCount":"68","leftBreakPoint":"chr22:23631808:+","rightBreakpoint":"chr9:133729451:+","left_tx_exon":"NM_004327:exon13","right_tx_exon":"NM_005157:exon2","prot_fusion_type":"INFRAME","spliceType":"ONLY_REF_SPLICE","largeAnchorSupport":"YES_LDAS","leftBreakDinuc":"GT","RightBreakDinuc":"AG","annots":"BCR->ArcherDX_panel,FoundationOne_panel,breakpoint_cluster_region,ABL1->ABL_proto-oncogene_1,_non-receptor_tyrosine_kinase,FoundationOne_panel,OncocartaV1_panel,OncomapV4_panel,Cosmic{samples=5990,mutations=5142,papers=196},Mitelman{MDS_NOS=2,ALL=5,Nonneo_hemat=2,AUL=2,DLBL=2,AML=14,Heart=7,AL_bi=2,Skin=2,MM=2,CML_ab_t=291,BL=2,RA=2},chimerdb_omim:{AcuteLymphocyticLeukemia},chimerdb_omim:{ChronicMyelogenousLeukemia},chimerdb_pubmed{Chronic myelogenous leukaemia (CML),Chronic myelogeneous leukaemia (CML),acute myelogenous leukemia (AML),chronic myeloid leukemia(CML),chronic myeloid leukemias (CML),Philadelphia positive leukaemia,acute lymphoblastic leukemia(ALL),K562,chronic neutrophilic leukemia and multiple myeloma (IgG kappa),Leukemia,chronic lymphocytic leukemia,acute myeloid leukemia(AML),Chronic myelogenous leukemia (CML),\"acute lymphoblastic leukemia (ALL), Chronic myelogeneous leukaemia (CML)\",myelodysplastic syndromes (MDS),Philadelphiapositive chronic myelogenous leukemia ,chronic myelomonocytic leukemia,chronic myelogenous leukemia(CML),\"CML, ALL\",Philadelphianegative chronic myeloid leukaemia,severalleukaemia,B cell precursor leukemia cells,Tcell acute lymphoblastic leukemia (TALL),\"chronic granulocytic leukaemiam, chronic myeloid leukaemias, acute myeloid leukaemia\",acute lymphoblastic leukemia.,\"chronic myeloid leukemia (CML), acute lymphoblastic leukemia(APL)\",chronic myeloid leukemia (CML),\"chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), acute myeloid leukemia(AML), myeloproliferative disorder (MPD)\",Chronic myelogenous leukemia (CML) acute lymphoblastic leukemias (ALL),chronic myeloid leukaemia,childhood acute lymphoblastic leukemia,Chronic myelogenous leukemia (CML) ,\"chronic myeloid leukaemia (CML), ALL and AML\",chronic myeloid leukaemia(CML),Chronic myeloid leukemia (CML),\"chronic myelocytic leukaemia, acute lymphoblastic leukaemia\",\"chronic myeloid leukemia (CML), acute myeloid leukemia (AML)\",\"Tcell acute lymphoblastic leukemia, acute myelomonocytic leukemia\",chronic myelogenous leukaemia (CML),\"chronic myelogenous leukemia(CML), acute lymphoblastic leukemia(ALL)\",Chronic Myeloid Leukaemia (CML),childhood ALL,\"PreB acute lymphoblastic leukemia(ALL), positive chronic myelogenous leukemia (CML)\",chronic myelogenous leukemia (CML),\"chronic myelogenous leukemia (CML), acute myeloid leukemia (AML)\",CML,chronic myeloid leukemia ,acute leukemia,adult acute lymphoblastic leukemia(ALL),leukemia,Chronic myeloid leukemia (CML) ,\"chronic myelogenous leukemia (CML),myelodysplastic syndromes (MDS),acute myelogenous leukemia(AML)\",\"erythroleukemia, chronic myeloid leukemia (CML)\",acute B lymphocytic leukemia,acute undifferentiated leukemia (AUL),acute lymphoblastic leukemia,\"chronic myeloid leukemia (CML), Ph+ ALL\",Philadelphia chromosome (Ph) positive Chronic myeloid leukaemia (CML),\"Philadelphia chromosomenegative (Ph()) nonHodgkin's lymphomas (NHLs), Phpositive (Ph(+)) chronic myelogenous leukemia (CML)\",chronic granulocytic leukemia,chronic myelogenous leukemia,Chronic myeloid leukemia(CML),chronic myeloid leukaemia (CML),\"chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL)\",\"acute lymphoblastic leukemia(ALL), chronic myeloid leukemia (CML), biphenotypic leukemia\",\"chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL)\",Philadelphia chromosomepositive leukemias,\"chronic myeloid leukemia(CML), acute lymphoblastic leukemia (ALL)\",Acute lymphoblastic leukemia (ALL),thrombocythemia,Philadelphia (Ph)positive acute lymphoblastic leukemia (ALL),Chronic myeloid leukaemia (CML),chronic myeloid leukemia,acute lymphoblastic leukemia (ALL),two Ph chromosome positive chronic myelogenous leukemia,Chronic Myeloid Leukemia (CML),Chronic myeloid leukemia,chronic myelocytic leukemia (CML),acute nonlymphocytic leukaemia (ANLL),Chronic myelogenous leukemia,\"chronic myelogenous leukemia(CML), mediastinal tumor\",Blineage acute lymphoblastic leukemia(Blineage ALL),leukemogenesis,Acute leukaemia,leukemic cells ,\"chronic myelogenous leukaemia(CML), Ewing's sarcoma\",\"chronic myeloid leukemia, acute lymphoblastic leukemia\",Chronic myelogenous leukemia(CML)},{Klijn_CCL:Lymphoid=4},INTERCHROMOSOMAL[chr22--chr9]","cds_left_id":"NM_004327","cds_left_range":"1-2707","cds_right_id":"NM_005157","cds_right_range":"80-3393","fusion_model":"chr22|+|[0]23523148-23524426[0]|[1]23595986-23596167[2]|[0]23603137-23603241[2]|[0]23603542-23603727[2]|[0]23610595-23610702[2]|[0]23613719-23613779[0]|[1]23615268-23615320[2]|[0]23615821-23615961[2]|[0]23626164-23626285[1]|[2]23627220-23627388[2]|[0]23629346-23629465[2]|[0]23630284-23630359[0]|[1]23631704-23631808[0]<==>chr9|+|[1]133729451-133729624[0]|[1]133730188-133730483[2]|[0]133738150-133738422[2]|[0]133747516-133747600[0]|[1]133748247-133748424[1]|[2]133750255-133750439[0]|[1]133753802-133753954[0]|[1]133755455-133755544[0]|[1]133755887-133756051[0]|[1]133759356-133761070[2]","fusion_cds":"atggtggacccggtgggcttcgcggaggcgtggaaggcgcagttcccggactcagagcccccgcgcatggagctgcgctcagtgggcgacatcgagcaggagctggagcgctgcaaggcctccattcggcgcctggagcaggaggtgaaccaggagcgcttccgcatgatctacctgcagacgttgctggccaaggaaaagaagagctatgaccggcagcgatggggcttccggcgcgcggcgcaggcccccgacggcgcctccgagccccgagcgtccgcgtcgcgcccgcagccagcgcccgccgacggagccgacccgccgcccgccgaggagcccgaggcccggcccgacggcgagggttctccgggtaaggccaggcccgggaccgcccgcaggcccggggcagccgcgtcgggggaacgggacgaccggggaccccccgccagcgtggcggcgctcaggtccaacttcgagcggatccgcaagggccatggccagcccggggcggacgccgagaagcccttctacgtgaacgtcgagtttcaccacgagcgcggcctggtgaaggtcaacgacaaagaggtgtcggaccgcatcagctccctgggcagccaggccatgcagatggagcgcaaaaagtcccagcacggcgcgggctcgagcgtgggggatgcatccaggcccccttaccggggacgctcctcggagagcagctgcggcgtcgacggcgactacgaggacgccgagttgaacccccgcttcctgaaggacaacctgatcgacgccaatggcggtagcaggcccccttggccgcccctggagtaccagccctaccagagcatctacgtcgggggcatgatggaaggggagggcaagggcccgctcctgcgcagccagagcacctctgagcaggagaagcgccttacctggccccgcaggtcctactccccccggagttttgaggattgcggaggcggctataccccggactgcagctccaatgagaacctcacctccagcgaggaggacttctcctctggccagtccagccgcgtgtccccaagccccaccacctaccgcatgttccgggacaaaagccgctctccctcgcagaactcgcaacagtccttcgacagcagcagtccccccacgccgcagtgccataagcggcaccggcactgcccggttgtcgtgtccgaggccaccatcgtgggcgtccgcaagaccgggcagatctggcccaacgatggcgagggcgccttccatggagacgcagatggctcgttcggaacaccacctggatacggctgcgctgcagaccgggcagaggagcagcgccggcaccaagatgggctgccctacattgatgactcgccctcctcatcgccccacctcagcagcaagggcaggggcagccgggatgcgctggtctcgggagccctggagtccactaaagcgagtgagctggacttggaaaagggcttggagatgagaaaatgggtcctgtcgggaatcctggctagcgaggagacttacctgagccacctggaggcactgctgctgcccatgaagcctttgaaagccgctgccaccacctctcagccggtgctgacgagtcagcagatcgagaccatcttcttcaaagtgcctgagctctacgagatccacaaggagttctatgatgggctcttcccccgcgtgcagcagtggagccaccagcagcgggtgggcgacctcttccagaagctggccagccagctgggtgtgtaccgggccttcgtggacaactacggagttgccatggaaatggctgagaagtgctgtcaggccaatgctcagtttgcagaaatctccgagaacctgagagccagaagcaacaaagatgccaaggatccaacgaccaagaactctctggaaactctgctctacaagcctgtggaccgtgtgacgaggagcacgctggtcctccatgacttgctgaagcacactcctgccagccaccctgaccaccccttgctgcaggacgccctccgcatctcacagaacttcctgtccagcatcaatgaggagatcacaccccgacggcagtccatgacggtgaagaagggagagcaccggcagctgctgaaggacagcttcatggtggagctggtggagggggcccgcaagctgcgccacgtcttcctgttcaccgacctgcttctctgcaccaagctcaagaagcagagcggaggcaaaacgcagcagtatgactgcaaatggtacattccgctcacggatctcagcttccagatggtggatgaactggaggcagtgcccaacatccccctggtgcccgatgaggagctggacgctttgaagatcaagatctcccagatcaagaatgacatccagagagagaagagggcgaacaagggcagcaaggctacggagaggctgaagaagaagctgtcggagcaggagtcactgctgctgcttatgtctcccagcatggccttcagggtgcacagccgcaacggcaagagttacacgttcctgatctcctctgactatgagcgtgcagagtggagggagaacatccgggagcagcagaagaagtgtttcagaagcttctccctgacatccgtggagctgcagatgctgaccaactcgtgtgtgaaactccagactgtccacagcattccgctgaccatcaataaggaagAAGCCCTTCAGCGGCCAGTAGCATCTGACTTTGAGCCTCAGGGTCTGAGTGAAGCCGCTCGTTGGAACTCCAAGGAAAACCTTCTCGCTGGACCCAGTGAAAATGACCCCAACCTTTTCGTTGCACTGTATGATTTTGTGGCCAGTGGAGATAACACTCTAAGCATAACTAAAGGTGAAAAGCTCCGGGTCTTAGGCTATAATCACAATGGGGAATGGTGTGAAGCCCAAACCAAAAATGGCCAAGGCTGGGTCCCAAGCAACTACATCACGCCAGTCAACAGTCTGGAGAAACACTCCTGGTACCATGGGCCTGTGTCCCGCAATGCCGCTGAGTATCTGCTGAGCAGCGGGATCAATGGCAGCTTCTTGGTGCGTGAGAGTGAGAGCAGTCCTGGCCAGAGGTCCATCTCGCTGAGATACGAAGGGAGGGTGTACCATTACAGGATCAACACTGCTTCTGATGGCAAGCTCTACGTCTCCTCCGAGAGCCGCTTCAACACCCTGGCCGAGTTGGTTCATCATCATTCAACGGTGGCCGACGGGCTCATCACCACGCTCCATTATCCAGCCCCAAAGCGCAACAAGCCCACTGTCTATGGTGTGTCCCCCAACTACGACAAGTGGGAGATGGAACGCACGGACATCACCATGAAGCACAAGCTGGGCGGGGGCCAGTACGGGGAGGTGTACGAGGGCGTGTGGAAGAAATACAGCCTGACGGTGGCCGTGAAGACCTTGAAGGAGGACACCATGGAGGTGGAAGAGTTCTTGAAAGAAGCTGCAGTCATGAAAGAGATCAAACACCCTAACCTGGTGCAGCTCCTTGGGGTCTGCACCCGGGAGCCCCCGTTCTATATCATCACTGAGTTCATGACCTACGGGAACCTCCTGGACTACCTGAGGGAGTGCAACCGGCAGGAGGTGAACGCCGTGGTGCTGCTGTACATGGCCACTCAGATCTCGTCAGCCATGGAGTACCTGGAGAAGAAAAACTTCATCCACAGAGATCTTGCTGCCCGAAACTGCCTGGTAGGGGAGAACCACTTGGTGAAGGTAGCTGATTTTGGCCTGAGCAGGTTGATGACAGGGGACACCTACACAGCCCATGCTGGAGCCAAGTTCCCCATCAAATGGACTGCACCCGAGAGCCTGGCCTACAACAAGTTCTCCATCAAGTCCGACGTCTGGGCATTTGGAGTATTGCTTTGGGAAATTGCTACCTATGGCATGTCCCCTTACCCGGGAATTGACCTGTCCCAGGTGTATGAGCTGCTAGAGAAGGACTACCGCATGGAGCGCCCAGAAGGCTGCCCAGAGAAGGTCTATGAACTCATGCGAGCATGTTGGCAGTGGAATCCCTCTGACCGGCCCTCCTTTGCTGAAATCCACCAAGCCTTTGAAACAATGTTCCAGGAATCCAGTATCTCAGACGAAGTGGAAAAGGAGCTGGGGAAACAAGGCGTCCGTGGGGCTGTGAGTACCTTGCTGCAGGCCCCAGAGCTGCCCACCAAGACGAGGACCTCCAGGAGAGCTGCAGAGCACAGAGACACCACTGACGTGCCTGAGATGCCTCACTCCAAGGGCCAGGGAGAGAGCGATCCTCTGGACCATGAGCCTGCCGTGTCTCCATTGCTCCCTCGAAAAGAGCGAGGTCCCCCGGAGGGCGGCCTGAATGAAGATGAGCGCCTTCTCCCCAAAGACAAAAAGACCAACTTGTTCAGCGCCTTGATCAAGAAGAAGAAGAAGACAGCCCCAACCCCTCCCAAACGCAGCAGCTCCTTCCGGGAGATGGACGGCCAGCCGGAGCGCAGAGGGGCCGGCGAGGAAGAGGGCCGAGACATCAGCAACGGGGCACTGGCTTTCACCCCCTTGGACACAGCTGACCCAGCCAAGTCCCCAAAGCCCAGCAATGGGGCTGGGGTCCCCAATGGAGCCCTCCGGGAGTCCGGGGGCTCAGGCTTCCGGTCTCCCCACCTGTGGAAGAAGTCCAGCACGCTGACCAGCAGCCGCCTAGCCACCGGCGAGGAGGAGGGCGGTGGCAGCTCCAGCAAGCGCTTCCTGCGCTCTTGCTCCGCCTCCTGCGTTCCCCATGGGGCCAAGGACACGGAGTGGAGGTCAGTCACGCTGCCTCGGGACTTGCAGTCCACGGGAAGACAGTTTGACTCGTCCACATTTGGAGGGCACAAAAGTGAGAAGCCGGCTCTGCCTCGGAAGAGGGCAGGGGAGAACAGGTCTGACCAGGTGACCCGAGGCACAGTAACGCCTCCCCCCAGGCTGGTGAAAAAGAATGAGGAAGCTGCTGATGAGGTCTTCAAAGACATCATGGAGTCCAGCCCGGGCTCCAGCCCGCCCAACCTGACTCCAAAACCCCTCCGGCGGCAGGTCACCGTGGCCCCTGCCTCGGGCCTCCCCCACAAGGAAGAAGCTGGAAAGGGCAGTGCCTTAGGGACCCCTGCTGCAGCTGAGCCAGTGACCCCCACCAGCAAAGCAGGCTCAGGTGCACCAGGGGGCACCAGCAAGGGCCCCGCCGAGGAGTCCAGAGTGAGGAGGCACAAGCACTCCTCTGAGTCGCCAGGGAGGGACAAGGGGAAATTGTCCAGGCTCAAACCTGCCCCGCCGCCCCCACCAGCAGCCTCTGCAGGGAAGGCTGGAGGAAAGCCCTCGCAGAGCCCGAGCCAGGAGGCGGCCGGGGAGGCAGTCCTGGGCGCAAAGACAAAAGCCACGAGTCTGGTTGATGCTGTGAACAGTGACGCTGCCAAGCCCAGCCAGCCGGGAGAGGGCCTCAAAAAGCCCGTGCTCCCGGCCACTCCAAAGCCACAGTCCGCCAAGCCGTCGGGGACCCCCATCAGCCCAGCCCCCGTTCCCTCCACGTTGCCATCAGCATCCTCGGCCCTGGCAGGGGACCAGCCGTCTTCCACCGCCTTCATCCCTCTCATATCAACCCGAGTGTCTCTTCGGAAAACCCGCCAGCCTCCAGAGCGGATCGCCAGCGGCGCCATCACCAAGGGCGTGGTCCTGGACAGCACCGAGGCGCTGTGCCTCGCCATCTCTAGGAACTCCGAGCAGATGGCCAGCCACAGCGCAGTGCTGGAGGCCGGCAAAAACCTCTACACGTTCTGCGTGAGCTATGTGGATTCCATCCAGCAAATGAGGAACAAGTTTGCCTTCCGAGAGGCCATCAACAAACTGGAGAATAATCTCCGGGAGCTTCAGATCTGCCCGGCGACAGCAGGCAGTGGTCCAGCGGCCACTCAGGACTTCAGCAAGCTCCTCAGTTCGGTGAAGGAAATCAGTGACATAGTGCAGAGGTAG","fusion_transl":"MVDPVGFAEAWKAQFPDSEPPRMELRSVGDIEQELERCKASIRRLEQEVNQERFRMIYLQTLLAKEKKSYDRQRWGFRRAAQAPDGASEPRASASRPQPAPADGADPPPAEEPEARPDGEGSPGKARPGTARRPGAAASGERDDRGPPASVAALRSNFERIRKGHGQPGADAEKPFYVNVEFHHERGLVKVNDKEVSDRISSLGSQAMQMERKKSQHGAGSSVGDASRPPYRGRSSESSCGVDGDYEDAELNPRFLKDNLIDANGGSRPPWPPLEYQPYQSIYVGGMMEGEGKGPLLRSQSTSEQEKRLTWPRRSYSPRSFEDCGGGYTPDCSSNENLTSSEEDFSSGQSSRVSPSPTTYRMFRDKSRSPSQNSQQSFDSSSPPTPQCHKRHRHCPVVVSEATIVGVRKTGQIWPNDGEGAFHGDADGSFGTPPGYGCAADRAEEQRRHQDGLPYIDDSPSSSPHLSSKGRGSRDALVSGALESTKASELDLEKGLEMRKWVLSGILASEETYLSHLEALLLPMKPLKAAATTSQPVLTSQQIETIFFKVPELYEIHKEFYDGLFPRVQQWSHQQRVGDLFQKLASQLGVYRAFVDNYGVAMEMAEKCCQANAQFAEISENLRARSNKDAKDPTTKNSLETLLYKPVDRVTRSTLVLHDLLKHTPASHPDHPLLQDALRISQNFLSSINEEITPRRQSMTVKKGEHRQLLKDSFMVELVEGARKLRHVFLFTDLLLCTKLKKQSGGKTQQYDCKWYIPLTDLSFQMVDELEAVPNIPLVPDEELDALKIKISQIKNDIQREKRANKGSKATERLKKKLSEQESLLLLMSPSMAFRVHSRNGKSYTFLISSDYERAEWRENIREQQKKCFRSFSLTSVELQMLTNSCVKLQTVHSIPLTINKEEALQRPVASDFEPQGLSEAARWNSKENLLAGPSENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGVRGAVSTLLQAPELPTKTRTSRRAAEHRDTTDVPEMPHSKGQGESDPLDHEPAVSPLLPRKERGPPEGGLNEDERLLPKDKKTNLFSALIKKKKKTAPTPPKRSSSFREMDGQPERRGAGEEEGRDISNGALAFTPLDTADPAKSPKPSNGAGVPNGALRESGGSGFRSPHLWKKSSTLTSSRLATGEEEGGGSSSKRFLRSCSASCVPHGAKDTEWRSVTLPRDLQSTGRQFDSSTFGGHKSEKPALPRKRAGENRSDQVTRGTVTPPPRLVKKNEEAADEVFKDIMESSPGSSPPNLTPKPLRRQVTVAPASGLPHKEEAGKGSALGTPAAAEPVTPTSKAGSGAPGGTSKGPAEESRVRRHKHSSESPGRDKGKLSRLKPAPPPPPAASAGKAGGKPSQSPSQEAAGEAVLGAKTKATSLVDAVNSDAAKPSQPGEGLKKPVLPATPKPQSAKPSGTPISPAPVPSTLPSASSALAGDQPSSTAFIPLISTRVSLRKTRQPPERIASGAITKGVVLDSTEALCLAISRNSEQMASHSAVLEAGKNLYTFCVSYVDSIQQMRNKFAFREAINKLENNLRELQICPATAGSGPAATQDFSKLLSSVKEISDIVQR*","pfam_left":"Bcr-Abl_Oligo|3-75|3.6e-43^RhoGEF|503-689|1.1e-37^IQ_SEC7_PH|724-769|4.7e-06^PH_5|727-865|6.6e-05^PH|740-864|5.3e-06^Bcr-Abl_Oligo|781-802|0.45^C2|913-1007|2.2e-09^PH|919-973|0.56^RhoGAP|1068-1218|7.9e-52","pfam_right":"SH3_1-PARTIAL|~80-113|1.6e-15^SH3_9-PARTIAL|~80-117|1.3e-11^SH3_2-PARTIAL|~80-118|1.9e-10^SH3_3|82-116|9.2e-08^SH3_6|83-112|0.00021^SH2|127-202|1.4e-26^Pkinase_Tyr|242-492|3.3e-102^Pkinase|244-491|2.1e-51^Haspin_kinase|307-388|9.1e-07^F_actin_bind|1027-1130|2.2e-33"}]